For decades, doctors have told patients suffering from worn-out joints that damaged cartilage has very little ability to repair itself. Once the protective tissue begins to deteriorate, the damage is often considered permanent.
But a remarkable scientific discovery may be challenging that long-held belief.
Researchers at Stanford Medicine have identified a biological mechanism that appears capable of reactivating cartilage regeneration in aging joints. By blocking a specific enzyme associated with aging, scientists successfully stimulated cartilage repair in mice and observed encouraging responses in human cartilage samples.
The findings, published in the prestigious scientific journal Science, could eventually transform the way osteoarthritis and age-related joint deterioration are treated.
However, while the discovery represents an important advance in regenerative medicine, the experimental treatment has not yet been proven to restore cartilage in living human patients.
Why Damaged Cartilage Is So Difficult to Repair
Cartilage is a smooth, flexible connective tissue that covers the ends of bones inside joints. It acts as a protective cushion, allowing bones to glide over one another with minimal friction.
Healthy cartilage plays an essential role in everyday activities such as walking, climbing stairs, bending, exercising, and even standing comfortably.
Unlike many other tissues, however, cartilage has no direct blood supply. This limits its access to nutrients and the repair mechanisms that help other parts of the body recover from injuries.
As people age, cartilage may gradually become thinner, lose some of its structural integrity, and become less effective at absorbing mechanical pressure.
These changes can contribute to osteoarthritis, a degenerative joint condition associated with pain, stiffness, swelling, and reduced mobility.
Although medications, physical therapy, and lifestyle modifications can help manage symptoms, rebuilding cartilage damaged by widespread osteoarthritis remains one of medicine’s greatest challenges.
That is precisely what makes the latest research so intriguing.
Scientists Identified an Aging-Related Enzyme That May Block Cartilage Regeneration
The breakthrough centers on an enzyme known as 15-hydroxyprostaglandin dehydrogenase, or 15-PGDH.
Scientists have classified this enzyme as a gerozyme, a term describing certain enzymes that become more abundant with age and contribute to declining tissue function.
Researchers discovered that cartilage from older mice contained approximately twice as much 15-PGDH as cartilage from younger animals.
This observation raised an important question: Could higher levels of this enzyme be interfering with the body’s ability to maintain and repair joint cartilage?
To investigate, the research team developed experiments using a compound designed to inhibit the enzyme’s activity.
The results suggested that reducing 15-PGDH activity could help restore regenerative processes that had become less active with age.
Instead of simply reducing inflammation or temporarily relieving pain, the experimental approach appeared to influence the underlying biological mechanisms involved in cartilage deterioration.
What Happened When Researchers Blocked the Enzyme?
In laboratory experiments, scientists administered a 15-PGDH inhibitor to older mice whose knee cartilage had deteriorated naturally with age.
They tested both systemic administration and injections delivered directly into the affected joints.
Following treatment, researchers observed significant improvements in cartilage structure.
The previously thinned cartilage became thicker, and further analysis indicated that the newly produced tissue had characteristics of hyaline cartilage.
This distinction is particularly important.
Hyaline cartilage is the specialized, smooth tissue naturally found on the ends of bones in healthy joints. It provides superior mechanical properties compared with fibrocartilage, a type of repair tissue that can form after certain cartilage injuries.
The researchers also observed reductions in osteoarthritis-associated pain behaviors in experimental animals.
These findings suggested that the treatment was doing more than temporarily masking joint discomfort.
It appeared to be promoting genuine tissue regeneration in the animal models.
The Most Surprising Discovery: Existing Cartilage Cells Became More Youthful
One of the most interesting aspects of the Stanford research was how cartilage regeneration occurred.
Scientists initially suspected that stem cells might be responsible for producing the new tissue.
Instead, the experiments revealed something unexpected.
The treatment appeared to change the behavior of existing cartilage cells, known as chondrocytes.
Chondrocytes are responsible for producing and maintaining the extracellular matrix that gives cartilage its strength, flexibility, and shock-absorbing properties.
As cartilage ages, these cells can become less effective at maintaining healthy tissue. Some also develop patterns of gene activity associated with inflammation, deterioration, and abnormal tissue changes.
After researchers inhibited 15-PGDH, many existing chondrocytes shifted toward gene-expression patterns resembling those of healthier, younger cartilage cells.
In other words, rather than relying on an entirely new population of stem cells, the treatment appeared to encourage older cartilage cells to resume some of their normal tissue-maintenance functions.
This discovery could have implications extending beyond osteoarthritis because it suggests that certain age-related changes in cellular behavior may be more reversible than previously assumed.
Could the Treatment Also Prevent Arthritis After Joint Injuries?
The researchers investigated another important possibility: whether blocking 15-PGDH could protect cartilage following traumatic joint injuries.
Knee injuries, particularly those involving the anterior cruciate ligament (ACL), can substantially increase the risk of developing osteoarthritis later in life.
Even after successful surgical repair, some individuals experience progressive cartilage deterioration over the following years.
To study this process, researchers used mice with knee injuries designed to mimic certain consequences of ACL damage.
The experimental animals received the enzyme inhibitor twice weekly for four weeks after injury.
Compared with untreated animals, the treated mice demonstrated substantially less cartilage deterioration and greater protection against the development of osteoarthritis-like changes.
They also showed improvements in how they used the affected limb.
Although findings from animal injury models cannot be directly applied to human patients, the results suggest that future regenerative therapies might have two important applications: repairing existing cartilage damage and protecting vulnerable joints after injury.
Human Cartilage Samples Responded to the Experimental Treatment
Perhaps the most encouraging aspect of the research involved experiments using human cartilage tissue.
Scientists obtained samples from patients undergoing total knee replacement surgery because of advanced osteoarthritis.
These samples were particularly valuable because they came from joints already affected by substantial cartilage deterioration.
The researchers exposed the tissue to the experimental 15-PGDH inhibitor under controlled laboratory conditions.
After approximately one week, treated samples showed changes associated with improved cartilage health.
The scientists observed reduced activity of genes associated with cartilage degradation, along with signs of renewed production of articular cartilage.
This finding suggests that the biological pathway identified in mice may also function in human cartilage.
However, there is an important limitation.
Human tissue responding to a treatment in a laboratory is not the same as proving that the treatment can safely regenerate cartilage inside a living person’s joint.
Human clinical trials are still necessary to determine whether the approach can produce meaningful, lasting improvements in patients with osteoarthritis.
Could This Discovery Help People Avoid Knee Replacement Surgery?
For people with advanced osteoarthritis, joint replacement surgery is sometimes the most effective option when pain and mobility limitations become severe.
Modern knee and hip replacements can significantly improve quality of life, but surgery still involves recovery time, rehabilitation, and potential complications.
A treatment capable of restoring functional cartilage could offer an entirely different approach.
Rather than replacing damaged joint surfaces with artificial components, doctors might eventually be able to encourage the body to repair some of its own tissue.
Researchers are particularly interested in whether future medications or joint injections could activate cartilage regeneration without requiring major surgery.
Nevertheless, several questions remain unanswered.
Scientists must establish how much cartilage can be regenerated in humans, whether repaired tissue remains durable under everyday mechanical stress, and whether repeated treatment would be necessary.
They must also determine the treatment’s safety, particularly because 15-PGDH influences biological pathways involved in several tissues throughout the body.
At present, there is no evidence that this experimental approach can reliably eliminate the need for joint replacement surgery in humans.
Why This Research Could Change Our Understanding of Aging
For many years, aging-related cartilage degeneration has been viewed largely as a consequence of accumulated mechanical stress and limited tissue repair.
The new findings introduce another possibility.
Some of the loss of regenerative capacity may result from changes in cellular signaling that occur as the body gets older.
If those signals can be safely modified, researchers may eventually be able to restore certain repair functions that were previously considered permanently diminished.
The enzyme 15-PGDH has also attracted scientific attention because of its involvement in tissue aging and regeneration in other organs.
Previous experimental research has investigated its role in muscle, bone, nerve, and blood-cell biology.
However, the response observed in cartilage appears distinctive because the tissue regeneration occurred primarily through changes in existing cells rather than the expansion of stem-cell populations.
This could provide researchers with a new framework for studying how aging tissues lose their ability to repair themselves.
What About Other Cartilage-Regeneration Treatments?
The Stanford discovery is part of a much larger effort to develop treatments that address the structural damage caused by osteoarthritis.
Scientists worldwide are investigating several promising approaches, including cell-based therapies, tissue-engineered implants, biological scaffolds, and medications targeting cartilage metabolism.
Some techniques are already used to repair specific, localized cartilage defects in carefully selected patients.
These procedures are different from reversing widespread osteoarthritis throughout an entire joint.
Other approaches, including mesenchymal stromal cell treatments and experimental regenerative injections, have produced encouraging results in some clinical studies.
Yet evidence remains inconsistent, and meaningful cartilage regeneration has not been reliably demonstrated across large patient populations.
A small 2026 human study investigating another experimental cartilage-repair therapy reported promising imaging and symptom findings, but its early-stage design means larger controlled trials are needed.
The broader field is advancing, but scientists continue to distinguish improvements in pain from actual restoration of healthy cartilage.
A patient may feel better after treatment without necessarily experiencing cartilage regrowth.
That distinction is essential when evaluating claims about regenerative medicine.
Can Diet, Exercise, or Supplements Help Regrow Cartilage Naturally?
As interest in cartilage regeneration grows, many people are searching for foods, supplements, and natural treatments capable of rebuilding damaged joints.
Although nutrition and lifestyle influence joint health, there is currently no convincing clinical evidence that any particular food, herb, or over-the-counter supplement can reliably regrow cartilage lost to osteoarthritis.
Certain habits can nevertheless support joint function and help manage symptoms.
Regular, appropriately selected exercise strengthens the muscles surrounding joints and can improve stability, flexibility, and mobility.
For individuals carrying excess body weight, weight management can reduce mechanical stress on weight-bearing joints such as the knees and hips.
A balanced diet containing adequate protein, vitamin C, and other essential nutrients supports normal connective-tissue maintenance.
Foods rich in unsaturated fats, vegetables, fruits, and other nutrient-dense ingredients can also contribute to overall metabolic health.
Collagen, glucosamine, and chondroitin supplements are frequently marketed for joint support, but clinical findings are mixed, and none should be considered a proven solution for regenerating lost cartilage.
Most importantly, reducing joint pain through lifestyle changes should not be confused with reversing structural damage.
When Could a Cartilage-Regeneration Treatment Become Available?
The 15-PGDH discovery represents an important step toward developing a potential disease-modifying treatment for osteoarthritis.
But transforming a laboratory breakthrough into an approved medication requires several stages of clinical development.
Researchers must establish suitable doses, evaluate side effects, study how the drug behaves in the body, and determine whether improvements observed in animal experiments can be reproduced in people.
Larger clinical trials would then need to demonstrate not only measurable cartilage changes but also meaningful benefits in pain, mobility, and long-term joint function.
An oral inhibitor of the same enzyme has already undergone early clinical investigation for age-related muscle weakness, providing some initial human safety information.
That does not establish its safety or effectiveness as a cartilage-regeneration treatment.
As of November 2026, 15-PGDH inhibition remains experimental for osteoarthritis, and no approved medication has been demonstrated to reliably reverse established cartilage loss throughout arthritic joints.
The Bottom Line: A New Chapter in Joint Regeneration?
The idea that damaged cartilage might someday be repaired by reactivating the body’s existing cells would have seemed highly ambitious only a few years ago.
Now, researchers have demonstrated that interfering with an aging-associated enzyme can stimulate cartilage regeneration in mice and produce promising biological changes in human cartilage studied outside the body.
Although there is still a substantial gap between these findings and an effective treatment for patients, the research offers a compelling new direction.
Instead of accepting age-related cartilage loss as an entirely irreversible process, scientists are beginning to investigate whether some of the biological mechanisms responsible for that deterioration can be modified.
For millions of people living with osteoarthritis, the most important development may not be a miracle cure available tomorrow, but the possibility of future treatments that address damaged cartilage itself rather than focusing exclusively on symptom relief.
The central question is no longer simply whether aging cartilage can respond to regenerative signals. It is whether scientists can safely turn those signals into lasting recovery for human joints.
And that is the next challenge for regenerative medicine.
